{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:11:14Z","timestamp":1790143874990,"version":"4.0.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The current study compared the clinical efficacy and immunological effects of subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) in children with house dust mite (HDM)-induced allergic asthma and explored immune markers associated with treatment response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study retrospectively included 125 children with HDM-induced allergic asthma, of which 53 patients received SCIT and 72 patients received SLIT. Clinical outcomes, pulmonary function, and immunological parameters were evaluated at baseline and after 12 months of treatment. Immunological assessments included total IgE, HDM-specific IgE, IgG4, cytokines, peripheral eosinophils, and fractional exhaled nitric oxide (FeNO). Multivariable regression and correlation analyses were performed to identify factors associated with clinical improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Both SCIT and SLIT significantly improved asthma control and pulmonary function. ACT scores increased, whereas FeNO levels and eosinophil counts decreased in both groups. IgG4 and IL-10 levels increased significantly, while IL-4 and IL-5 decreased. No significant differences were observed between SCIT and SLIT in the magnitude of these improvements. In exploratory regression analyses, changes in IgG4, IL-10, and IL-4 were associated with improvement in asthma control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this retrospective cohort, SCIT and SLIT were associated with similar improvements in asthma control, selected pulmonary-function measures, and immune markers over the 12-month observation period. Changes in concomitant asthma medications during follow-up could not be accounted for and may have influenced the observed outcomes. The study did not assess the long-term sustainability of these benefits or post-treatment effects; therefore, longer prospective follow-up is required to evaluate the comparative long-term efficacy of the two treatment modalities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1909274","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:49:32Z","timestamp":1790142572000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative clinical efficacy and immunological modulation of subcutaneous vs. sublingual allergen immunotherapy in children with house dust mite-induced allergic asthma: a retrospective cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Chunyun","family":"Zeng","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Nanxiang Branch of Ruijin Hospital","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajie","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nanxiang Branch of Ruijin Hospital","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiting","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nanxiang Branch of Ruijin Hospital","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nanxiang Branch of Ruijin Hospital","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nanxiang Branch of Ruijin Hospital","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1136\/thx.2006.070169","article-title":"Worldwide trends in the prevalence of asthma symptoms: phase III of the international study of asthma and allergies in childhood (Isaac)","volume":"62","author":"Pearce","year":"2007","journal-title":"Thorax"},{"key":"B2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1939-4551-7-12","article-title":"Allergic diseases and asthma: a global public health concern and a call to action","volume":"7","author":"Pawankar","year":"2014","journal-title":"World Allergy Organ J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaci.2014.10.012","article-title":"Respiratory allergy caused by house dust mites: what do we really know?","volume":"136","author":"Calder\u00f3n","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11882-016-0649-y","article-title":"House dust mite allergens: new discoveries and relevance to the allergic patient","volume":"16","author":"Thomas","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ni.3049","article-title":"The immunology of asthma","volume":"16","author":"Lambrecht","year":"2015","journal-title":"Nat Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/bmj.322.7283.390","article-title":"Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study","volume":"322","author":"Illi","year":"2001","journal-title":"Br Med J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41533-023-00330-1","article-title":"Key recommendations for primary care from the 2022 global initiative for asthma (Gina) update","volume":"33","author":"Levy","year":"2023","journal-title":"NPJ Prim Care Respir Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"Cd001186","DOI":"10.1002\/14651858.Cd001186","article-title":"Allergen immunotherapy for asthma","author":"Abramson","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jaci.2010.11.030","article-title":"Mechanisms of allergen-specific immunotherapy","volume":"127","author":"Akdis","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1111\/all.13208","article-title":"Allergen immunotherapy for allergic asthma: a systematic review and meta-analysis","volume":"72","author":"Dhami","year":"2017","journal-title":"Allergy"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cvsm.2018.08.001","article-title":"Update on allergen immunotherapy","volume":"49","author":"Mueller","year":"2019","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"B12","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1056\/nejm199908123410702","article-title":"Long-term clinical efficacy of grass-pollen immunotherapy","volume":"341","author":"Durham","year":"1999","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/WOX.0b013e3181c6c379","article-title":"Sub-lingual immunotherapy: world allergy organization position paper 2009","volume":"2","author":"Canonica","year":"2009","journal-title":"World Allergy Organ J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"Cd002893","DOI":"10.1002\/14651858.CD002893.pub2","article-title":"Sublingual immunotherapy for allergic rhinitis","volume":"2010","author":"Radulovic","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1001\/jama.2016.3964","article-title":"Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial","volume":"315","author":"Virchow","year":"2016","journal-title":"JAMA"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.jaci.2017.10.010","article-title":"Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers","volume":"140","author":"Shamji","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1111\/all.14582","article-title":"Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma","volume":"75","author":"Breiteneder","year":"2020","journal-title":"Allergy"},{"key":"B18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s40521-017-0117-5","article-title":"Update on biomarkers to monitor clinical efficacy response during and post treatment in allergen immunotherapy","volume":"4","author":"Kouser","year":"2017","journal-title":"Curr Treat Options Allergy"},{"key":"B19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41577-022-00786-1","article-title":"Allergen immunotherapy: past, present and future","volume":"23","author":"Durham","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2500\/aap.2022.43.220033","article-title":"Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease","volume":"43","author":"Creticos","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/cells11020212","article-title":"Allergen immunotherapy: current and future trends","volume":"11","author":"Pav\u00f3n-Romero","year":"2022","journal-title":"Cells"},{"key":"B22","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jaci.2009.06.053","article-title":"The minimally important difference of the asthma control test","volume":"124","author":"Schatz","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1016\/j.jaip.2021.08.018","article-title":"Efficacy of subcutaneous and sublingual immunotherapy for house dust mite allergy: a network meta-analysis-based comparison","volume":"9","author":"Kim","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B24","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2217\/imt-2020-0123","article-title":"Sublingual immunotherapy for food allergy and its future directions","volume":"12","author":"Schworer","year":"2020","journal-title":"Immunotherapy"},{"key":"B25","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3390\/jpm13050845","article-title":"Mechanisms of allergen immunotherapy and potential biomarkers for clinical evaluation","volume":"13","author":"Sahiner","year":"2023","journal-title":"J Pers Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.jaci.2021.10.001","article-title":"Advances in asthma: new understandings of asthma\u2019s natural history, risk factors, underlying mechanisms, and clinical management","volume":"148","author":"Miller","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.iac.2015.08.004","article-title":"Biomarkers for allergen immunotherapy: a \u201cPanoromic\u201d view","volume":"36","author":"Moingeon","year":"2016","journal-title":"Immunol Allergy Clin North Am"},{"key":"B28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/02770903.2024.2391441","article-title":"Efficacy and safety of subcutaneous and sublingual allergen immunotherapy in the treatment of asthma in children: a systematic review and meta-analysis","volume":"62","author":"Yang","year":"2025","journal-title":"J Asthma"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1274241","DOI":"10.3389\/fimmu.2023.1274241","article-title":"Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: a systematic review and meta-analysis","volume":"14","author":"Yang","year":"2023","journal-title":"Front Immunol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1909274\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:49:33Z","timestamp":1790142573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1909274\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":29,"alternative-id":["10.3389\/fmed.2026.1909274"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1909274","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"article-number":"1909274"}}